You searched for "AMM"

2004 results found

Treat-and-extend regimen in treatment of patients with type 3 neovascularisation

Type 3 neovascularisation, also known as retinal angiomatous proliferation is a distinct subtype of neovascular AMD characterised by intraretinal neovascularisation. This retrospective study included 17 eyes diagnosed with type 3 neovascularisation who were changed from pro-re-nata (PRN) based treatment regime...

Intravitreal Ziv-Aflibercept: safety analysis

Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...

The meaning of life

Supercomputer: “The answer to the great question of Life, the Universe and Everything is…”Programmer: “Yes…?”Supercomputer: “42. It was a tough assignment”.Programmer: “42? Is that all you have got to show for seven and a half million years work?” In this...

Introducing the Interest in Ophthalmology Association

We are very excited to announce the launch of Interest in Ophthalmology Association (InOA), a brand-new organisation to unite and support all those interested in eye health and vision sciences, starting in 2026! What is InOA? The InOA is a...

Robotic assisted orbital surgery (RAOS) – a novel approach to orbital malignancy surgery

Robotic technology in ENT surgery has been used in certain areas of head and neck cancer care but, in this article, we hear of an exciting development from the team at Guy’s & St Thomas’. Advances in surgical robotic technology...

Vision passport to be discussed at OSA June 10 meeting

The Digital Eye Care Alliance (DECA) meeting at the OSA Summer Belfry event on June 10, is opening its doors to non-OSA members who would like to know more about the rapid advances in digital eyecare.

Imposter syndrome is a term we have all come across - but what does it actually mean for ophthalmology trainees?

This research project affiliated with Imperial College London and backed by ethical approval aims to quantify the prevalence of imposter syndrome (IS) in Ophthalmology trainees, in addition to exploring an understanding of why, how, and when IS develops. In addition,...

Vision measurements vs. self-rating

The aim of this study was to evaluate the association between self-rated vision status and tests of visual acuity, contrast sensitivity, stereoacuity, bilateral visual field and self-reported visual function in specific domains of near and far vision. The goal was...

Opportunity to take part in research for eyecare professionals advising patients about driving

Claire Howard and Lauren Hepworth are running a study looking which looks to eyecare professionals in the UK who advise patients on DVLA/DVA driving vision standards, as part of their role. The aim of this research is to determine eyecare...

What can artificial intelligence do to improve sustainability in the delivery of ophthalmic care?

The 2025 NHS 10-year plan, titled ‘Fit for the Future’, emphasises a significant shift from analogue to digital, with a strong focus on integrating AI and other technologies to transform healthcare. The plan aims to make the NHS the "most...

Specialty-driven EMR for paperless clinical environment – insights for an informed choice

Deployment of specialty-driven (or specialty-specific) electronic medical record (EMR) systems across UK ophthalmology units appears to be growing rapidly at the expense of generic, multiuse digital technology packages. Experience further suggests that open source systems can play a significant role...

An update on inherited retinal disorders (part 2): Approaches to therapy for IRDs

Part 1 of this topic can be found here There are currently no proven cures for inherited retinal disease (IRD). However, multiple avenues of research are being investigated to better understand disease mechanisms and trial potential therapies that may slow...